Prism AI Therapeutics provides an AI-first multi-omics management platform that uniquely enables biotech companies and health systems to unlock the value of real-world multi-omic data and develop the next generation of drugs and biomarkers. The platform is powered by proprietary quantum mechanics-based AI/ML, and is supported by end-to-end global biospecimen sourcing and molecular profiling services.
We and our partners have experimentally validated that our AI/ML is uniquely able to make accurate, precise, clinically actionable, and mechanistically interpretable discoveries from real-world multi-omic data. We excel in (i) discovering biomarkers of response and survival, disease models, and drug targets that consistently validate across studies and over time in federated, small-cohort, noisy, and high-dimensional data, (ii) integrating multi-omic data for discovery and validation of multi-modal predictors, (iii) separating the predictors from normal demographic variations, and (iv) removing systematic batch effects from the data.
Let’s join forces to conquer disease.
Company Details
- Employees
- 4
- Founded
- -
- Address
- Salt Lake City, Utah, Us
- Industry
- Software Development
- NAICS
-
Software Publishers
- Website
- https://prism-ai.com/
- Keywords
- San Diego.
- HQ
- Salt Lake City, Utah
Prism Ai Therapeutics Questions
Prism Ai Therapeutics's website is https://prism-ai.com/
Prism Ai Therapeutics's LinkedIn profile is https://www.linkedin.com/company/prism-ai
Prism Ai Therapeutics has
4 employees.
View email and phone details for 4
employees at Prism Ai Therapeutics.
Prism Ai Therapeutics's industry is
Software Development
Prism Ai Therapeutics's top competitors are
Prismai,
Data4cure, Inc.,
Autonnomy,
Symbiocelltech, Llc,
Veracyte Inc. | C2i Genomics,
Rebel Medicine,
Prisma Ai,
Sethera Therapeutics,
Certis Oncology Solutions, Inc.,
Prism.ai.
Prism Ai Therapeutics's categories are Software Development
Prism Ai Therapeutics's founding year is 2024
